Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      1Program in Genetic Epidemiology and Statistical Genetics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 2Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 3Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts. 4Dana-Farber Cancer Institute, Boston, Massachusetts. 5UCLA Path & Lab Med, Los Angeles, California. 6Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii. 7Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee. 8Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel. 9Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 10Fred A, Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. 11Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada. 12Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, California. 13Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. 14Department of Pathology, Landspitali University Hospital, Reykjavik, Iceland. 15BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland. 16Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. 17Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada. 18Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. 19Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. 20Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington. 21Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin. 22Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy. 23High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain. 24Department of Gynecology and Obstetrics, Comprehensive Cancer Center ER-EMN, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany. 25Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. 26Centro de Investigaci-n en Red de Enfermedades Raras (CIBERER), Madrid, Spain. 27Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. 28Institute of Biochemistry and Genetics, Ufa Federal Research Centre of the Russian Academy of Sciences, Ufa, Russia. 29Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland. 30Fundaci-n Pœblica Galega Medicina Xen-mica, Santiago De Compostela, Spain. 31Instituto de Investigacion Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain. 32Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 33Department of Oncology, University Hospital, Karolinska Institute, Stockholm, Sweden. 34VIB Center for Cancer Biology, VIB, Leuven, Belgium. 35Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Leuven, Belgium. 36Department of Radiation Oncology, Hannover Medical School, Hannover, Germany. 37Gynaecology Research Unit, Hannover Medical School, Hannover, Germany. 38NN Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus. 39Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. 40Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. 41Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. 42Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy. 43Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden. 44Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany. 45iFIT-Cluster of Excellence, University of Tuebingen, Tuebingen, Germany. 46German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. 47Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. 48Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia. 49Medical Faculty, Universidad de La Sabana, Bogota, Colombia. 50Division of Molecular Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 51Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany. 52Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. 53Molecular Biology of Breast Cancer, University Womens Clinic Heidelberg, University of Heidelberg, Heidelberg, Germany. 54Medical Oncology Department, Hospital Cl'nico San Carlos, Instituto de Investigaci-n Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. 55Section of Molecular Genetics, Dept, of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy. 56Research Department, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. 57Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. 58Division of Molecular Carcinogenesis, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands. 59Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. 60Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, Georgia. 61Department of Gynaecological Oncology, Chris OÕBrien Lifehouse and The University of Sydney, Camperdown, New South Wales, Australia. 62Oncology and Genetics Unit, Instituto de Investigacion Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain. 63Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 64Division of Cancer Epidemiology and Genetics, Department of Health and Human Services, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. 65Departments of Pediatrics and Medicine, Columbia University, New York, New York. 66Centre for Medical Genetics, Ghent University, Gent, Belgium. 67Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia. 68Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. 69Department of Oncology and Metabolism, Sheffield Institute for Nucleic Acids (SInFoNiA), University of Sheffield, Sheffield, UK. 70Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK. 71Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 72Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania. 73Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. 74Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. 75Hereditary Cancer Genetics Group, Area of Clinical and Molecular Genetics, Vall dHebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain. 76Clinical and Molecular Genetics Area, University Hospital Vall dHebron, Barcelona, Spain. 77Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 78Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK. 79Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. 80Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, London, UK. 81Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK. 82Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 83Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden. 84Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. 85LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany. 86David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California. 87The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK. 88Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark. 89Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritosဩ, Athens, Greece. 90The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Ramat Gan, Israel. 91Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel. 92School of Public Health, Curtin University, Perth, Western Australia, Australia. 93Schools of Medicine and Public Health, Division of Cancer Prevention & Control Research, Jonsson Comprehensive Cancer Centre, UCLA, Los Angeles, California. 94Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, Boston, Massachusetts. 95Division of Genetics and Epidemiology, Institute of Cancer Research, London, UK. 96Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia. 97Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia. 98Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia. 99Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kanas. 100Department of Medicine, McGill University, Montreal, Quebec, Canada. 101Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada. 102Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. 103Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland. 104Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France. 105Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California. 106Department of Oncology, Sšdersjukhuset, Stockholm, Sweden. 107Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. 108City of Hope Clinical Cancer Genetics Community Research Network, Duarte, California. 109School of Population and Global Health, The University of Western Australia, Perth, Western Australia, Australia. 110Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 111Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. 112Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois. 113The University of Chicago Pritzker School of Medicine, Chicago, Illinois. 114NN Petrov Institute of Oncology, St. Petersburg, Russia. 115Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia. 116Research Centre for Genetic Engineering and Biotechnology 'Georgi D, Efremov', Macedonian Academy of Sciences and Arts, Skopje Republic of North Macedonia, North Macedonia. 117Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland. 118Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. 119State Research Institute Innovative Medicine Center, Vilnius, Lithuania. 120Department of Medicine, Division of Hematology/Oncology, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 121Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California. 122Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York. 123David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California, Los Angeles, California. 124Department of Genetics and Fundamental Medicine, Bashkir State Medical University, Ufa, Russia. 125Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland. 126Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway. 127Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. 128Molecular Diagnostic Unit, Hereditary Cancer Program, ICO-IDIBELL (Bellvitge Biomedical Research Institute, Catalan Institute of Oncology), CIBERONC, Barcelona, Spain. 129Departement de Ge netique, CHU de Grenoble, Grenoble, France. 130Institut Curie, Paris, France. 131Mines ParisTech, Fontainebleau, France. 132Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France. 133Department of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona. 134Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington. 135Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. 136Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finland. 137Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland. 138Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland. 139Department of Clinical Science and Education, Sšdersjukhuset, Karolinska Institutet, Stockholm, Sweden. 140Moores Cancer Center, University of California San Diego, La Jolla, California. 141Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California. 142Immunology and Molecular Oncology Unit, Veneto Institute of Oncology ÊIOV-IRCCS, Padua, Italy. 143Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Greece. 144Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany. 145MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK. 146Department of Electron Microscopy/Molecular Pathology and The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus. 147Faculty of Medicine, University of Heidelberg, Heidelberg, Germany. 148NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Buffalo, New York. 149Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. 150Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada. 151Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California. 152Leuven Multidisciplinary Breast Center, Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. 153Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. 154Latvian Biomedical Research and Study Centre, Riga, Latvia. 155Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York. 156Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary. 157Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois. 158Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 159Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark. 160Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. 161Genome Diagnostics Program, IFOM-The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy. 162Department of Medicine Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. 163Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland. 164Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Oulu, Finland. 165Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. 166Clinical Genetics, Karolinska Institutet, Stockholm, Sweden. 167Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan. 168Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. 169Medical Oncology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain. 170Department of Oncology, University Hospital of Larissa, Larissa, Greece. 171Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina. 172Research Oncology, GuyÕs Hospital, King's College London, London, UK. 173Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 174Faculty of Information Technology, Monash University, Melbourne, Victoria, Australia. 175Center for Hereditary Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. 176Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. 177Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, New South Wales, Australia. 178Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Callaghan, New South Wales, Australia. 179Hunter Medical Research Institute, John Hunter Hospital, Newcastle, New South Wales, Australia. 180Department of Internal Medicine, Division of Medical Oncology, University of Kansas Medical Center, Westwood, Kanas. 181Genomics Center, Centre Hospitalier Universitaire de Quebec-Universite Laval, Research Center, Quebec City, Qubec, Canada. 182Department of Clinical Genetics, Aarhus University Hospital, Aarhus N, Denmark. 183Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. 184Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia. 185Population Oncology, BC Cancer, Vancouver, British of Columbia, Canada. 186School of Population and Public Health, University of British Columbia, Vancouver, British of Columbia, Canada. 187The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, Perth, Western Australia, Australia. 188Division of Breast Cancer Research, The Institute of Cancer Research, London, UK. 189Faculty of Medicine, University of Southampton, Southampton, UK. 190Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina. 191Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal. 192Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York. 193Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain. 194Department of Clinical Genetics, Odense University Hospital, Odence C, Denmark. 195Department of Medicine, Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 196Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montreal, Quebec, Canada. 197Department of Medical Genetics, University of Cambridge, Cambridge, UK. 198Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio. 199Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. 200Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts. 201Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, Minnesota. 202Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. 203Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands. 204Department of Genetics, University of Pretoria, Arcadia, South Africa. 205Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy. 206Hospital Clínico Universitario (SERGAS), Universidad de Santiago de Compostela, CIMUS, Santiago de Compostela, España. 207Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina. 208Clinical Cancer Genomics, City of Hope, Duarte, California.
    • بيانات النشر:
      Wiley
    • الموضوع:
      2020
    • Collection:
      Hirsla - Landspítali University Hospital research archive
    • نبذة مختصرة :
      To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Download ; Previous transcriptome-wide association studies (TWAS) have identified breast cancer risk genes by integrating data from expression quantitative loci and genome-wide association studies (GWAS), but analyses of breast cancer subtype-specific associations have been limited. In this study, we conducted a TWAS using gene expression data from GTEx and summary statistics from the hitherto largest GWAS meta-analysis conducted for breast cancer overall, and by estrogen receptor subtypes (ER+ and ER-). We further compared associations with ER+ and ER- subtypes, using a case-only TWAS approach. We also conducted multigene conditional analyses in regions with multiple TWAS associations. Two genes, STXBP4 and HIST2H2BA, were specifically associated with ER+ but not with ER- breast cancer. We further identified 30 TWAS-significant genes associated with overall breast cancer risk, including four that were not identified in previous studies. Conditional analyses identified single independent breast-cancer gene in three of six regions harboring multiple TWAS-significant genes. Our study provides new information on breast cancer genetics and biology, particularly about genomic differences between ER+ and ER- breast cancer. Keywords: GWAS; TWAS; breast cancer subtype; causal gene. ; Cancer Research UK European Union's Horizon 2020 Research and Innovation Programme European Union (EU) United States Department of Health & Human Services National Institutes of Health (NIH) - USA Cancer UK Genome Canada Canadian Institutes of Health Research (CIHR) Ministere de l'Economie, Science et Innovation du Quebec through Genome Quebec Quebec Breast Cancer Foundation United States Department of Health & Human Services National Institutes of Health (NIH) - USA Post-Cancer GWAS initiative (GAME-ON initiative) Department of Defence Canadian Institutes of Health ...
    • ISSN:
      1098-2272
    • Relation:
      Feng H, Gusev A, Pasaniuc B, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol. 2020;44(5):442-468. doi:10.1002/gepi.22288; http://hdl.handle.net/2336/621480; Genetic epidemiology
    • الرقم المعرف:
      10.1002/gepi.22288
    • Rights:
      © 2020 The Authors. Genetic Epidemiology published by Wiley Periodicals, Inc. ; Open Access - Opinn aðgangur
    • الرقم المعرف:
      edsbas.5683FCEF